Bacillus Bathwater Therapy for Atopic Dermatitis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional bathing therapies for atopic dermatitis using fermentation powder of Makomo are inconsistent, often leading to foul odor and exacerbation of dermatitis due to unstable dominant bacteria populations and poor water quality management.

Innovation Solution

A biological spa therapy method that maintains a bathwater environment with a dominant concentration of Bacillus bacteria (at least 10^5 CFU/mL) to stabilize water quality, inhibit pathogenic bacteria, and promote therapeutic effects for atopic and infectious dermatitis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If fermentation powder of Makomo is added to bathwater and not changed over a long period, then therapeutic effects may be temporarily achieved, but dominant bacteria become unstable and pathogenic bacteria may grow leading to foul odor and exacerbation of dermatitis

Engineering Contradiction:
Improvetherapeutic effect consistencyVSAvoiddominant bacteria population stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent changes the bacterial concentration parameter by specifying a minimum threshold of 10^5 CFU/mL for Bacillus bacteria. This quantitative parameter control ensures reliable therapeutic effects while preventing bacterial instability and pathogen overgrowth that occur in conventional practices without such specifications.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If bathwater is not changed over a long period of time, then some effectiveness is caused, but anaerobic metabolism occurs leading to foul odor and harmful pathogenic bacteria growth

Engineering Contradiction:
Improvetherapeutic effectivenessVSAvoidfoul odor and pathogenic bacteria
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent applies preliminary anti-action by pre-establishing a dominant population of Bacillus bacteria (at least 10^5 CFU/mL) that proactively prevents anaerobic metabolism and pathogenic bacteria growth. This preliminary protective measure counteracts the harmful effects before they occur, allowing long-term bathwater use without foul odor or pathogen proliferation.

Inventive Principle:
Principle #9Preliminary anti-action

3Quantity of substance

If large amount of fermentation powder is added (400 g or more per month), then some effectiveness is achieved, but anaerobic metabolism occurs due to poor temperature management leading to harmful effects

Engineering Contradiction:
Improvefermentation powder amountVSAvoidanaerobic metabolism products
Core Design Contradiction:
Quantity of substanceVSObject-generated harmful factors

Solution Approach 1:

The patent changes the critical parameter from fermentation powder quantity to Bacillus bacteria concentration threshold (10^5 CFU/mL). This parameter transformation eliminates the need for large fermentation powder amounts and prevents anaerobic metabolism by ensuring adequate aerobic bacterial population, regardless of temperature management quality.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method effectively alleviates symptoms of atopic dermatitis and infectious dermatitis by maintaining a stable ecosystem of Bacillus bacteria, reducing pathogenic microorganisms, and improving skin health without the need for steroids or antifungal agents.

Implementation Method 1

Bacillus bacteria decompose and metabolize waste products discharged from the human body, whereby inhibiting chemical substances harmful to dermatitis from occurring in the bathwater

Methodology Applied
Scientific EffectDecomposition (biological): Decomposition (biological)

Implementation Method 2

Bacillus bacteria have very low pathogenicity, have strong inhibitory effect against pathogenic bacteria such as dermal fungus and Staphylococcus aureus, and have strong inhibitory effect against pathogenic bacteria in the bathwater

Methodology Applied
Scientific EffectAntibacterial effect:

Data Source

PatentUS10004768B2Treatment of atopic dermatitis and infectious dermatitis with biological spa therapy
Publication Date: 2018.06.26 IRYOHOJIN KIYOKAI
  • US10004768B2 patent drawing
  • US10004768B2 patent drawing
  • US10004768B2 patent drawing

AI summary

Provided is a method for treatment of atopic dermatitis and infectious dermatitis with biological spa therapy. The method seeks to cure or alleviate symptoms of atopic dermatitis by bathing in a bathwater containing, as dominant bacteria, not less than 105 Bacillus bacteria per 1 mL of the bathwater.